Based Detection, Linguistic Biomarkers, Machine Learning, Explainable AI, Cognitive Decline Monitoring Share and Cite: de Filippis, R. and Al Foysal, A. (2025) Early Alzheimer’s Disease Detection from ...

July 25, 2024 (La Mesa) -- Sharp Grossmont Hospital is pleased to announce a free webinar focused on advanced treatments for Essential Tremor and Parkinson’s Disease. This informative session will ...

Readers are invited to listen to the brief audio at the beginning of this piece. The layered voices are intended ...

In our latest CPD module, GP Dr Roger Henderson outlines the features, causes and management strategies for essential tremor, and explains how nurses in general practice and the community can support ...

Essential tremor (ET) is a common movement disorder affecting about 2% of the American population, and more than 20% of those over 90 years old. Despite its prevalence and decades of study, ...

Abstract: The pathogenesis of essential tremor (ET) remains unclear, and the efficacy of related drug treatment is inadequate for proper tremor control. Hence, in the current study, consecutive ...

Nerve stimulation has emerged as a potential therapy for essential tremor, the most common movement disorder affecting the arms. Unlike deep brain stimulation, which requires surgery, transcutaneous ...

An error has occurred. Please try again. With a Centralmaine.com subscription, you can gift 5 articles each month. It looks like you do not have any active ...

Botox is a brand-name injectable botulinum toxin that can be prescribed off-label for essential tremor. With off-label use, doctors prescribe a drug for a different condition than what it’s approved ...

HONOLULU — New imaging data may explain how transcutaneous afferent patterned stimulation (TAPS), a noninvasive, wearable therapy, works in patients with essential tremor (ET). In a small study that ...

Findings showed a statistically significant and clinically meaningful improvement in the mADL11 score at week 8 with ulixacaltamide vs placebo. Topline data were announced from two phase 3 trials ...

Seven months ago, independent clinical trial observers peeked at interim data for Praxis Precision Medicines’ essential tremor drug and recommended stopping the Phase 3 studies. Praxis kept going. On ...